Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
PACBPacific Biosciences of California(PACB) GlobeNewswire News Room·2024-07-23 21:05

MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, serving customers across the European scientific community. Novogene is a leading provider of genomic services and bioinformatics expertise, working with a wide range of leading research institutions, clinical and commerc ...